A detailed history of Exodus Point Capital Management, LP transactions in Liva Nova PLC stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 278,431 shares of LIVN stock, worth $13.6 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
278,431
Holding current value
$13.6 Million
% of portfolio
0.1%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$51.76 - $64.15 $14.4 Million - $17.9 Million
278,431 New
278,431 $15.3 Million
Q2 2023

Aug 10, 2023

SELL
$42.28 - $51.43 $2.5 Million - $3.04 Million
-59,159 Reduced 87.42%
8,515 $438,000
Q1 2023

May 11, 2023

BUY
$40.84 - $58.14 $2.76 Million - $3.93 Million
67,674 New
67,674 $2.95 Million
Q2 2022

Aug 19, 2022

SELL
$57.25 - $86.63 $159,326 - $241,091
-2,783 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$71.02 - $86.99 $197,648 - $242,093
2,783 New
2,783 $228,000
Q3 2021

Nov 15, 2021

SELL
$76.02 - $88.62 $752,445 - $877,160
-9,898 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$73.44 - $87.01 $726,909 - $861,224
9,898 New
9,898 $833,000
Q1 2021

May 17, 2021

SELL
$62.9 - $82.41 $4.88 Million - $6.4 Million
-77,636 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$46.01 - $68.74 $3.11 Million - $4.65 Million
67,677 Added 679.56%
77,636 $5.14 Million
Q3 2020

Nov 16, 2020

SELL
$41.91 - $57.81 $1.25 Million - $1.72 Million
-29,717 Reduced 74.9%
9,959 $450,000
Q2 2020

Aug 14, 2020

BUY
$39.87 - $56.9 $1.58 Million - $2.26 Million
39,676 New
39,676 $1.91 Million
Q1 2020

May 15, 2020

SELL
$34.22 - $76.49 $146,598 - $327,683
-4,284 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$68.92 - $85.27 $28,670 - $35,472
-416 Reduced 8.85%
4,284 $323,000
Q3 2019

Nov 14, 2019

BUY
$71.74 - $86.35 $337,178 - $405,845
4,700 New
4,700 $347,000

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.62B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.